Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality